Viewing Study NCT03733067


Ignite Creation Date: 2025-12-25 @ 12:31 AM
Ignite Modification Date: 2026-01-05 @ 12:11 AM
Study NCT ID: NCT03733067
Status: WITHDRAWN
Last Update Posted: 2023-12-04
First Post: 2018-11-06
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Safety and Efficacy of Abatacept for Treating Chronic Cytopenia in Cytotoxic T-Lymphocyte Antigen 4 (CTLA4) Haploinsufficiency
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module